David F. Bruhn

Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux

Richard Lee, Julian G. Hurdle, Jiuyu Liu et al. · Nature Medicine · 2014 · 192 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Patient perspectives on once‐weekly medications for diabetes

William H. Polonsky, Lawrence Fisher, Danielle Hessler et al. · Diabetes Obesity and Metabolism · 2010 · 128 citations

Pharmacy, Pharmacotherapy, Drug Information +16

Synthesis, Structure–Activity Relationship Studies, and Antibacterial Evaluation of 4-Chromanones and Chalcones, as Well as Olympicin A and Derivatives

Feng Li, Marcus M. Maddox, Md. Zahidul Alam et al. · Journal of Medicinal Chemistry · 2014 · 109 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

The economic burden of progressive chronic kidney disease among patients with type 2 diabetes

Suma Vupputuri, Teresa M. Kimes, Michael Calloway et al. · Journal of Diabetes and its Complications · 2013 · 81 citations

Medicine, Internal Medicine, Nephrology +15

Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties

E. Jeffrey North, Michaël Scherman, David F. Bruhn et al. · Bioorganic & Medicinal Chemistry · 2013 · 80 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacokinetics +10